Skills this job asks for
LeadershipSupply chainCompliance
Add your CV (free) to see which of these your CV is missing.
Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Business Introduction
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people’s lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients’ needs and have the highest probability of success. We’re uniting science, technology, and talent to get ahead of disease together.
Find out more:
Our approach to R&D
Position Summary
As VP, Global GMP Clinical Manufacturing Operations, you will lead the Medicines Global Clinical Manufacturing Operations function, ensuring the on time scale-up, manufacture, and supply of high-quality, fit-for-purpose, GMP-compliant products for clinical trials in a disciplined and compliant environment. You will play a critical role in ensuring patient safety, clinical data integrity, and delivery of R&D objectives.
This is a significant leadership role in delivering R&D portfolio milestones by ensuring all clinical trials are supported seamlessly and on time, and that Drug Substance and Drug Product multi-modality processes are developed and successfully transferred to GSC and/or external manufacturing partners.
You will be responsible for driving innovation and modernisation across GMP Manufacturing Operations, building on a strong foundation of operational excellence while ensuring the function remains positioned to support the evolving needs of the R&D portfolio.
Reporting to the SVP, Global Clinical Manufacturing and Supply Chain (CMSC) within DDS, you will serve as a member of the CMSC Leadership Team.
You will work closely with senior leaders across DDS, GSC, Finance, Quality, Regulatory, and Technical functions to ensure effective delivery of clinical supply requirements across the R&D portfolio. You will also represent DDS and CMSC in senior cross-functional, governance, and external forums as required.
You will provide leadership across six manufacturing locations:
• UK (Ware)
• USA (Upper Merion 38, Upper Merion 29, Marietta)
• Italy (Parma)
• Singapore (Jurong)
Your organization will be responsible for:
• Drug Substance pilot plant operations
• Drug Product pilot plant operations (OSD and Steriles)
• Manufacturing automation
• Oversight of major capital projects, including the Marietta Steriles Facility, UM Biologics Flex Factory, and Jurong Oligonucleotides Facility
Key Responsibilities:
• Line leadership of global department of ca 300 scientists, engineering, process technicians and manufacturing experts across 6 sites across 4 countries: including 6 nodes/ Pilot Plants, and a total budget of >£100M.
• Leading the global medicines GMP Operations; accountable for the on time scale up, manufacture and supply to R&D GSK sponsored clinical trials, delivering high quality, GMP compliant drug substance, drug product across all modalities according to R&D objectives and compliance with all internal and external regulations and policies governing clinical supply chain.
• Accountability for the implementation of the functional strategy including modernisation and delivery of the optimised operation ready to support with flexibility the cross-modality R&D Portfolio.
• Driving the comprehensive modernization/digitalisation programme as part of deployment of CMC Digital Strategy & CMC Acceleration goals.
• Oversight and expert input into the design and building of the new GMP pilot plants being built at Marietta and UM Flex factory (major capital projects)
• Monitoring the external CMO landscape and a
Apply on employer site ↗